Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?

FK Knop - American Journal of Physiology-Endocrinology …, 2010 - journals.physiology.org
American Journal of Physiology-Endocrinology and Metabolism, 2010journals.physiology.org
During the last decades it has become clear that bile acids not only act as simple fat
solubilizers, but additionally represent complex hormonal metabolic integrators. Bile acids
activate both nuclear receptors (controlling transcription of genes involved in for example
bile acid, cholesterol, and glucose metabolism) and the cell surface G protein-coupled
receptor TGR5 (modulating energy expenditure in brown fat and muscle cells). It has been
shown that TGR5 is expressed in enteroendocrine L cells, which secrete the potent glucose …
During the last decades it has become clear that bile acids not only act as simple fat solubilizers, but additionally represent complex hormonal metabolic integrators. Bile acids activate both nuclear receptors (controlling transcription of genes involved in for example bile acid, cholesterol, and glucose metabolism) and the cell surface G protein-coupled receptor TGR5 (modulating energy expenditure in brown fat and muscle cells). It has been shown that TGR5 is expressed in enteroendocrine L cells, which secrete the potent glucose-lowering incretin hormone glucagon-like peptide-1 (GLP-1). Recently it was shown that bile acid-induced activation of TGR5 results in intestinal secretion of GLP-1 and that enhanced TGR5 signaling improves postprandial glucose tolerance in diet-induced obese mice. This Perspectives article presents these novel findings in the context of prior studies on nutrient-induced GLP-1 secretion and outlines the potential implications of bile acid-induced GLP-1 secretion in physiological, pathophysiological, and pharmacological perspectives.
American Physiological Society